Recent Recalls Weren’t a Headache for Johnson & Johnson Earnings
Johnson & Johnson (NYSE:JNJ) reported earnings after the bell on Tuesday morning, and shares are up 0.89 percent at the time of writing as the health care and pharmaceutical company beat expectations for both revenue and earnings.
Johnson & Johnson reported earnings per share of $1.36, up 8.8 percent from $1.25 in the third quarter of last year. Analysts had estimated the company would post earnings of $1.32 per share. Revenue came in at $17.58 billion, which beat estimates that placed the figure at $17.46 billion. The company’s revenue was $17.05 billion in 2012.
Johnson & Johnson’s consumer segment saw a small growth of 0.9 percent versus the third quarter of 2012. Baby care fell 4.8 percent, oral care fell 12.3 percent, wound care/other fell 9.8 percent, and women’s health fell 4.9 percent, while over-the-counter medicines grew 17.9 percent and skin care grew 3.6 percent.